Literature DB >> 27180613

The enigma of ceramide synthase regulation in mammalian cells.

Marthe-Susanna Wegner1, Susanne Schiffmann2, Michael John Parnham2, Gerd Geisslinger3, Sabine Grösch3.   

Abstract

Ceramide synthases (CerS) are key enzymes in the lipid metabolism of eukaryotic cells. Their products, ceramides (Cer), are components of cellular membranes but also mediate signaling functions in physiological processes such as proliferation, skin barrier function and cerebellar development. In pathophysiological processes such as multiple sclerosis and tumor progression, ceramide levels are altered, which can be ascribed, partly, to dysregulation of CerS gene transcription. Most publications deal with the effects of altered ceramide levels on physiological and pathophysiological processes, but the regulation of the appropriate CerS is frequently not investigated. This is insufficient for the clarification of the role of ceramides, because most ceramide species are generated by at least two CerS. The mechanisms of CerS regulation are manifold and it seems that each CerS isoform is regulated individually. For this reason, we discuss the different CerS separately in this review. From transcriptional regulation to alteration of protein activity, the possibilities to influence CerS are diverse. Furthermore, CerS are influenced by a variety of molecules including hormones and lipids. Without claiming completeness, we provide a résumé of the regulatory mechanisms for each CerS in mammalian cells and how dysregulation of these mechanisms during physiological processes may lead to pathophysiological processes.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ceramide synthases; Epigenetic; Post-translational; Regulation; Transcriptional; miR

Mesh:

Substances:

Year:  2016        PMID: 27180613     DOI: 10.1016/j.plipres.2016.03.006

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  43 in total

1.  Ceramide synthase 2 deficiency aggravates AOM-DSS-induced colitis in mice: role of colon barrier integrity.

Authors:  Stephanie Oertel; Klaus Scholich; Andreas Weigert; Dominique Thomas; Julia Schmetzer; Sandra Trautmann; Marthe-Susanna Wegner; Heinfried H Radeke; Natalie Filmann; Bernhard Brüne; Gerd Geisslinger; Irmgard Tegeder; Sabine Grösch
Journal:  Cell Mol Life Sci       Date:  2017-04-12       Impact factor: 9.261

2.  Expression of the SNAI2 transcriptional repressor is regulated by C16-ceramide.

Authors:  Ping Lu; Shai White-Gilbertson; Rose Nganga; Mark Kester; Christina Voelkel-Johnson
Journal:  Cancer Biol Ther       Date:  2019-03-05       Impact factor: 4.742

Review 3.  Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.

Authors:  Christina Voelkel-Johnson; James S Norris; Shai White-Gilbertson
Journal:  Adv Cancer Res       Date:  2018-06-20       Impact factor: 6.242

Review 4.  Sphingolipids and their metabolism in physiology and disease.

Authors:  Yusuf A Hannun; Lina M Obeid
Journal:  Nat Rev Mol Cell Biol       Date:  2017-11-22       Impact factor: 94.444

5.  Serine-Dependent Sphingolipid Synthesis Is a Metabolic Liability of Aneuploid Cells.

Authors:  Sunyoung Hwang; H Tobias Gustafsson; Ciara O'Sullivan; Gianna Bisceglia; Xinhe Huang; Christian Klose; Andrej Schevchenko; Robert C Dickson; Paola Cavaliere; Noah Dephoure; Eduardo M Torres
Journal:  Cell Rep       Date:  2017-12-26       Impact factor: 9.423

6.  Yeast mating: Ceramide acyl chain length matters?

Authors:  Teresa M Dunn; Kenneth Gable; Gongshe Han
Journal:  Cell Cycle       Date:  2018-01-02       Impact factor: 4.534

7.  Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function.

Authors:  Myung Jong Kim; Sohee Jeon; Lena F Burbulla; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2018-06-01       Impact factor: 6.150

Review 8.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

Review 9.  Therapeutic implications of bioactive sphingolipids: A focus on colorectal cancer.

Authors:  E Ramsay Camp; Logan D Patterson; Mark Kester; Christina Voelkel-Johnson
Journal:  Cancer Biol Ther       Date:  2017-07-07       Impact factor: 4.742

10.  UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells.

Authors:  Marthe-Susanna Wegner; Nina Schömel; Lisa Gruber; Stephanie Beatrice Örtel; Matti Aleksi Kjellberg; Peter Mattjus; Jennifer Kurz; Sandra Trautmann; Bing Peng; Martin Wegner; Manuel Kaulich; Robert Ahrends; Gerd Geisslinger; Sabine Grösch
Journal:  Cell Mol Life Sci       Date:  2018-03-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.